In vitro studies demonstrated that stimulation with fMLP or phorbol myristate acetate (PMA) can significantly enhance ROS generation by neutrophils from CLL patients compared with neutrophils from healthy controls (124). Here, FPR1 is linked to B-cell chronic lymphocytic leukemia.